News

WHO's Tedros: Hoping to launch big initiative this week to accelerate R&D of vaccines

"We hope to launch a big initiative this week to accelerate research and development of vaccines and design a mechanism for equitable distribution," World Health Organization (WHO) chief Tedros Adhanom Ghebreyesus said on Monday, per Reuters. 

Additional takeaways from WHO officials

"Large numbers of unrecognised transmission may be missed currently, but we need to see the results of serological studies in coming weeks."

"Further study needed on what causes some people to have a higher dose of exposure or more severe infection."

"Lockdowns in many situations are proving effective in dampening the flames in those countries."

"Lockdowns can only be exited step by step, looking at data and combining with public health measures."

Market sentiment

Risk-on flows continue to dominate the financial markets on Monday. As of writing, Wall Street's three main indexes were up between 5.5% and 5.4%.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.